The purpose of this research is to document and characterize iso- mechanisms in aspartic proteases. The central features of the proposed iso-mechanism are partially rate-limiting rehydration and reprotonation of the aspartic carboxyl groups in the active site. Evidence from this laboratory in support of iso-mechanisms for aspartic proteases (and other enzymes) is diverse and includes: (a) solvent isotope effects on maximal velocities, (b) solvent isotope effects on onsets of inhibition, (c) solvent isotope effects on inhibition constants, (d) product inhibition kinetic patterns, (e) dead-end inhibition patterns, (f) progress curve analysis, and (g) modified and traditional induced transport kinetics of Britton (i.e., transpeptidation and isotopic exchange, respectively). Original experimental designs described in the current proposal include: (a) comparisons of rate constants and isotope effects on the recovery of pepsin from time-dependent inhibition by pepstatin incurred in the presence and absence of substrates, (b) steady-state kinetics of the initial inhibition of pepsin by pepstatin as a function of substrate concentration and identity, (c) effects of changes in the reactivity of water on iso-mechanism kinetics, (d) proton inventories on transpeptidation reactions, (e) kinetic competency for transpeptidation of peptides blocked at either the carboxyl or amino terminus, and (f) a search for burst phenomena in transient-state kinetics of peptide hydrolysis using highly sensitive pH indicator assays. The significance this proposal derives from the family of enzymes to which pepsin belongs, the aspartic proteases. Studies on pepsin serve as models to a series of clinically-significant enzymes, including most notably the HIV protease and renal renin. Similar isotope effects have been reported, suggesting that a rate-limiting reprotonation may be a common feature of the aspartic proteases. If true, then this kinetic mechanism will have an important relevance to the design of inhibitors. These should be designated to bind to the form of enzyme that is present in the greatest concentration in vivo, which this proposal holds is a form of free enzyme that has not yet undergone rehydration and reprotonation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM046695-04A1
Application #
2184188
Study Section
Biochemistry Study Section (BIO)
Project Start
1992-01-01
Project End
1998-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Pharmacy
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Rebholz, K L; Northrop, D B (1994) Kinetics of enzymes with iso-mechanisms: dead-end inhibition of fumarase and carbonic anhydrase II. Arch Biochem Biophys 312:227-33
Northrop, D B; Rebholz, K L (1994) Kinetics of enzymes with iso-mechanisms: analysis and display of progress curves. Anal Biochem 216:285-90
Cho, Y K; Rebholz, K L; Northrop, D B (1994) Solvent isotope effects on the onset of inhibition of porcine pepsin by pepstatin. Biochemistry 33:9637-42
Rebholz, K L; Northrop, D B (1993) Kinetics of enzymes with iso-mechanisms: analysis of product inhibition. Biochem J 296 ( Pt 2):355-60